Your browser doesn't support javascript.
loading
Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
Liu, Hui-Na; Guo, Ning-Ning; Guo, Wang-Wei; Huang-Fu, Ming-Yi; Vakili, Mohammad Reza; Chen, Jie-Jian; Xu, Wen-Hong; Wei, Qi-Chun; Han, Min; Lavasanifar, Afsaneh; Gao, Jian-Qing.
Afiliação
  • Liu HN; Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
  • Guo NN; Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
  • Guo WW; Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
  • Huang-Fu MY; Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
  • Vakili MR; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, T6G 2E1, Alberta, Canada.
  • Chen JJ; Department of Radiation Oncology, Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, the Second Affiliated Hospital, Zhejiang University, College of Medicine, Hangzhou, 310058, China.
  • Xu WH; Department of Radiation Oncology, Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, the Second Affiliated Hospital, Zhejiang University, College of Medicine, Hangzhou, 310058, China.
  • Wei QC; Department of Radiation Oncology, Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, the Second Affiliated Hospital, Zhejiang University, College of Medicine, Hangzhou, 310058, China.
  • Han M; Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. hanmin@zju.edu.cn.
  • Lavasanifar A; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, T6G 2E1, Alberta, Canada. afsaneh@ualberta.ca.
  • Gao JQ; Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Acta Pharmacol Sin ; 39(10): 1681-1692, 2018 Oct.
Article em En | MEDLINE | ID: mdl-29849132
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Portadores de Fármacos / Doxorrubicina / Ácido Hialurônico / Mitocôndrias / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Portadores de Fármacos / Doxorrubicina / Ácido Hialurônico / Mitocôndrias / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article